212
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Influence of extremely low-frequency magnetic field on chemotherapy and electrochemotherapy efficacy in human Caco-2 colon cancer cells

, & ORCID Icon
Pages 177-183 | Received 18 Oct 2021, Accepted 05 Feb 2022, Published online: 09 Mar 2022

References

  • Alkis, M. E. 2021b. Effects of electroporation on cytotoxicity of 4-aminopyrimidin-2-(1H)-one based ligand and its Cobalt (II) and Ruthenium (II) complexes in MCF-7 cancer cells. Dicle. Med. J 48:498–506.
  • Alkış, M. E., K. Buldurun, N. Turan, Y. Alan, Ü. K. Yılmaz, and A. Mantarcı. 2020. Synthesis, characterization, antiproliferative of pyrimidine based ligand and its Ni(II) and Pd(II) complexes and effectiveness of electroporation. J. Biomol. Struct. Dyn 1–11.
  • Alkış, M. E., Ü. Keleştemür, Y. Alan, N. Turan, and K. Buldurun. 2021a. Cobalt and ruthenium complexes with pyrimidine based schiff base: Synthesis, characterization, anticancer activities and electrochemotherapy efficiency. J. Mol. Struct 1226:129402.
  • Baharara, J., N. Hosseini, and T. R. Farzin. 2016. Extremely low frequency electromagnetic field sensitizes cisplatin-resistant human ovarian adenocarcinoma cells via P53 activation. Cytotechnology 68:1403–13.
  • Basile, A., R. Zeppa, N. Pasquino, Arra, C., Ammirante, M., Festa, M., Barbieri, A., Giudice, A., Pascale, M., and Turco, M. C., et al. 2011. Exposure to 50 Hz electromagnetic field raises the levels of the anti-apoptotic protein BAG3 in melanoma cells. J. Cell. Physiol 226:2901–07.
  • Benassi, B., G. Filomeni, C. Montagna, Merla, C., Lopresto, V., Pinto, R., Marino, C., and Consales, C., et al. 2016. Extremely low frequency magnetic field (ELF-MF) exposure sensitizes SH-SY5Y cells to the pro-Parkinson’s disease toxin MPP. Mol. Neurobiol 53:4247–60.
  • Blackman, C. F., S. G. Benane, J. A. Elder, D. E. House, J. A. Lampe, and J. M. Faulk. 1980. Induction of calcium-ion efflux from brain tissue by radiofrequency radiation: Effect of sample number and modulation frequency on the power-density window. Bioelectromagnetics 1:35–43.
  • Campana, L. G., A. Testori, P. Curatolo, Quaglino, P., Mocellin, S., Framarini, M., Borgognoni, L., Ascierto, P. A., Mozzillo, N., and Guida, M., et al. 2016. Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors. Eur. J. Surg. Oncol 42:1914–23.
  • Chen, C., J. A. Evans, M. P. Robinson, S. W. Smye, and P. O’Toole. 2010. Electroporation of cells using EM induction of ac fields by a magnetic stimulator. Phys. Med. Biol 55:1219–29.
  • De Angelis, P. M., D. H. Svendsrud, K. L. Kravik, and T. Stokke. 2006. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol. Cancer 5:20.
  • Esmaeili, N., and M. Friebe. 2019. Electrochemotherapy: A review of current status, alternative IGP approaches, and future perspectives. J. Healthc. Eng 2019:2784516.
  • Falone, S., S. Santini Jr, V. Cordone, Cesare, P., Bonfigli, A., Grannonico, M., Di Emidio, G., Tatone, C., Cacchio, M., and Amicarelli, F., et al. 2017. Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms. Sci. Rep 7:11470.
  • Falone, S., S. Santini Jr, S. Di Loreto, V. Cordone, Grannonico, M., Cesare, P., Cacchio, M., and Amicarelli, F., et al. 2016. Improved mitochondrial and methylglyoxal-related metabolisms support hyperproliferation induced by 50 Hz magnetic field in neuroblastoma cells: Elf-mf alters metabolic state of cancer cells. J. Cell. Physiol 231:2014–25.
  • Feng, R.-M., Y.-N. Zong, S.-M. Cao, and R.-H. Xu. 2019. Current cancer situation in China: Good or bad news from the 2018 Global Cancer Statistics? Cancer. Commun (Lond) 39:22.
  • Ferioli, M., A. M. Perrone, M. Buwenge, Arcelli, A., Zamagni, A., Macchia, G., Deodato, F., Cilla, S., Tagliaferri, L., and De Terlizzi, F., et al. 2021. Electrochemotherapy of skin metastases from breast cancer: A systematic review. Clin. Exp. Metastasis 38:1–10.
  • Gafter, U., T. Malachi, Y. Ori, and H. Breitbart. 1997. The role of calcium in human lymphocyte DNA repair ability. J. Lab. Clin. Med 130:33–41.
  • Girgert, R., H. Schimming, W. Körner, C. Gründker, and V. Hanf. 2005. Induction of tamoxifen resistance in breast cancer cells by ELF electromagnetic fields. Biochem. Biophys. Res. Commun 336:1144–49.
  • Gomez-Monterrey, I., P. Campiglia, I. Scognamiglio, D. Vanacore, A. Dicitore, A. Lombardi, M. Caraglia, E. Novellino, and P. Stiuso. 2013. DTNQ-Pro, a mimetic dipeptide, sensitizes human colon cancer cells to 5-fluorouracil treatment. J. Amino. Acids 2013:509056.
  • González-Sarrías, A., J. Tomé-Carneiro, A. Bellesia, F. A. Tomás-Barberán, and J. C. Espín. 2015. The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells. Food Funct 6:1460–69.
  • Harland, J. D., and R. P. Liburdy. 1997. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics 18:555–62.
  • Jin, Z., C. Zong, B. Jiang, Z. Zhou, J. Tong, and Y. Cao. 2012. The effect of combined exposure of 900 MHz radiofrequency fields and doxorubicin in HL-60 cells. PLoS One 7:e46102.
  • Jordan, D. W., R. M. Gilgenbach, M. D. Uhler, L. H. Gates, and Y. Y. Lau. 2004. Effect of pulsed, high-power radiofrequency radiation on electroporation of mammalian cells. IEEE Trans. Plasma. Sci. IEEE Nucl. Plasma Sci. Soc 32:1573–78.
  • Kaszuba-Zwoinska, J., P. Chorobik, K. Juszczak, W. Zaraska, and P. J. Thor. 2012. Pulsed electromagnetic field affects intrinsic and endoplasmatic reticulum apoptosis induction pathways in MonoMac6 cell line culture. J. Physiol. Pharmacol 63:537–45.
  • Mahna, A., S. M. P. Firoozabadi, and Z. Shankayi. 2014. The effect of ELF magnetic field on tumor growth after electrochemotherapy. J. Membr. Biol 247:9–15.
  • Mansourian, M., M. Firoozabadi, and Z. M. Hasan. 2018. Effect of pulse-modulated gsm-900 mhz electromagnetic field on the electrochemotherapy efficacy of 4T-1 cells. Iran. J. Med. Phys 15:264–70.
  • Mansourian, M., M. Firoozabadi, and Z. M. Hassan. 2020. The role of 217-Hz ELF magnetic fields emitted from GSM mobile phones on electrochemotherapy mechanisms. Electromagn. Biol. Med 39:239–49.
  • Mansourian, M., S. M. P. Firoozabadi, and Z. M. Hassan. 2021. The effect of 900 MHz electromagnetic fields on biological pathways induced by electrochemotherapy. Electromagn. Biol. Med 40:158–68.
  • Mansourian, M., M. Firoozabadi, Z. M. Hassan, and Z. Shankayi. 2012. The effect of 217 Hz magnetic field of cell phone with different intensities on apoptosis of normal and cancerous cells treated with chemotherapy drug. Zahedan. J. Res. Med. Sci 14:29–33.
  • Mansourian, M., S. M. P. Firoozabadi, Z. Shankayi, and Z. M. Hassan. 2013. Magnetic fields with frequency of 217 Hz can reduce cell apoptosis caused by electrochemotherapy. Electromagn. Biol. Med 32:70–78.
  • Palumbo, R., D. Capasso, F. Brescia, Mita, P., Sarti, M., Bersani, F., and Scarfi, M. R., et al. 2006. Effects on apoptosis and reactive oxygen species formation by Jurkat cells exposed to 50 Hz electromagnetic fields. Bioelectromagnetics 27:159–62.
  • Pasi, F., L. Fassina, M. E. Mognaschi, Lupo, G., Corbella, F., Nano, R., and Capelli, E., et al. 2016. Pulsed electromagnetic field with temozolomide can elicit an epigenetic pro-apoptotic effect on glioblastoma T98G cells. Anticancer Res 36:5821–26.
  • Pirozzoli, M. C., C. Marino, G. A. Lovisolo, C. Laconi, L. Mosiello, and A. Negroni. 2003. Effects of 50 Hz electromagnetic field exposure on apoptosis and differentiation in a neuroblastoma cell line. Bioelectromagnetics 24:510–16.
  • Ruiz-Gómez, M. J., L. de la Peña, M. I. Prieto-Barcia, J. M. Pastor, L. Gil, and M. Martínez-Morillo. 2002. Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line: Influence of EMF on drug potency. Bioelectromagnetics 23:578–85.
  • Saczko, J., I. Kamińska, M. Kotulska, Bar, J., Choromańska, A., Rembiałkowska, N., Bieżuńska-Kusiak, K., Rossowska, J., Nowakowska, D., and Kulbacka, J., et al. 2014. Combination of therapy with 5-fluorouracil and cisplatin with electroporation in human ovarian carcinoma model in vitro. Biomed. Pharmacother 68:573–80.
  • Sersa, G., D. Miklavcic, M. Cemazar, Z. Rudolf, G. Pucihar, and M. Snoj. 2008. Electrochemotherapy in treatment of tumours. Eur. J. Surg. Oncol 34:232–40.
  • Strojan, P., A. Grošelj, G. Serša, Plaschke, C. C., Vermorken, J. B., Nuyts, S., de Bree, R., Eisbruch, A., Mendenhall, W. M., and Smee, R., et al. 2021. Electrochemotherapy in mucosal cancer of the head and neck: A systematic review. Cancers (Basel) 13:1254.
  • Tang, J.-Y., T.-W. Yeh, Y.-T. Huang, M.-H. Wang, and L.-S. Jang. 2019. Effects of extremely low-frequency electromagnetic fields on B16F10 cancer cells. Electromagn. Biol. Med 38:149–57.
  • Tiwari, P. K. 2015. Simulation and mathematical analyses of AC electric field driven apoptosis via microtubule disintegration. Jpn. J. Appl. Phys 54:097301.
  • Wang, M.-H., K.-W. Chen, D.-X. Ni, H.-J. Fang, L.-S. Jang, and C.-H. Chen. 2021. Effect of extremely low frequency electromagnetic field parameters on the proliferation of human breast cancer. Electromagn. Biol. Med 40:384–92.
  • Wócik-Piotrowicz, K., J. Kaszuba-Zwoińska, E. Rokita, Thor, P., Chrobik, P., Nieckarz, Z., and Michalski, J., et al. 2014. Influence of static and alternating magnetic fields on U937 cell viability. Folia Med. Cracov 54:21–33.
  • Zheng, H.-C. 2017. The molecular mechanisms of chemoresistance in cancers. Oncotarget 8:59950–64.
  • Zheng, X., J. Liu, X. Li, R. Tian, K. Shang, X. Dong, and B. Cao. 2021. Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells. Cancer Lett 497:190–201.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.